We have installed ReadSpeaker’s webReader, which allows visitors to instantly convert online content to audio on our website.
Click on the icon above to try this out, and take advantage of the full range of useful webReader features by clicking the link below.
Readspeaker website
This accessibility statement applies to www.audit.wales. This website is run by Audit Wales. We want as many people as possible to be able to use this website.
View accessibility statement
We’re always looking to improve the accessibility of this website. If you find any problems not listed on this page or think we’re not meeting accessibility requirements, contact:
info@audit.wales
Performance varies across Wales, but no health board has met the current waiting time target since 2020
Stronger and clearer national leadership is urgently needed to improve cancer services, along with a greater focus on prevention, according to a report by the Auditor General
The report, published today, examines the coherence of the national arrangements to drive improvements in cancer services in Wales.
The report found that despite increased investment, there is a continuing failure to meet the national performance target that 75% of cancer patients should start their first treatment within 62 days. No health board has met the target since August 2020, and it has never been met on an all-Wales level. Performance deteriorated after the pandemic and has been stable since early 2022 with between 52% and 61% starting their treatment within the target time. Waiting times for some cancer types (lower gastrointestinal, gynaecological, and urological cancers) are particularly long, with some patients waiting over 100 days to start treatment
Early detection and diagnosis are key to survival for most cancers. Screening plays a vital role in early detection. Positively, the national bowel screening programme has expanded to include more people using a more sensitive test. There are opportunities to increase the uptake of breast and cervical screening and make a decision about a national lung screening programme.
Cancer survival outcomes in Wales have improved over recent years but are still poor compared to other countries. Wales has the second highest cancer mortality rate in the UK after Scotland. Survival rates are worse for people living in deprived areas compared to more affluent areas.
Rising demand for cancer diagnosis and treatment is a significant challenge for NHS Wales. The number of newly diagnosed cancers has increased by 22% from 2002 to 2021. Numbers of suspected cancer referrals have also increased. Those referrals create demand even though more than 84% of patients who are referred with a suspected cancer go on to find out that they do not have cancer.
There are also challenges associated with gaps in staffing capacity.
The waiting list for cancer diagnosis and treatment has continued to increase. The Welsh Government wants the waiting list to return to pre-pandemic levels. However, the report shows that this is unlikely without a significant increase in diagnosis and treatment activity.
Addressing the challenges facing cancer services in Wales requires strong and clear national leadership. However, the report points to weaknesses in this area and in particular to a lack of clarity over the status of the national Cancer Improvement Plan for Wales that was launched in 2023. It also calls for greater clarity over the respective roles of the Welsh Government and the NHS Executive in overseeing and supporting improvement.
Around four in ten cancers each year in Wales are preventable. There are considerable opportunities to save lives and reduce pressure on NHS resources by tackling lifestyle factors which increase the risks of some cancers occurring in the first place. Those opportunities go beyond the prevention of cancer because many of the lifestyle risk factors for cancer are also risk factors for other major conditions which affect people’s well-being and consume significant amounts of NHS resource.
The Welsh Government’s Quality Statement, the identification of nationally optimised pathways and the publication of a Cancer Improvement Plan are all examples of a clear commitment to secure high quality cancer care for the people of Wales. However, despite this and increased investment over recent years, too many people are experiencing unacceptably long waits for cancer diagnosis and treatment. Variations in performance and outcomes persist within and between health bodies in Wales, and insufficient attention is being placed on prevention of the lifestyle factors that can cause cancer and other major health conditions. The arrangements for the national leadership and oversight of cancer services in Wales need to be clarified and strengthened as a matter of urgency. This must include a clear statement on the status of the NHS Wales Cancer Improvement Plan and how the Welsh Government and NHS Executive expect it to be used, alongside other programmes and initiatives, to shape the improvements which are needed in cancer services in Wales.